MPA and MIA collaboration
7 November 2019
In a boost for melanoma patients across the country, Melanoma Patients Australia and Melanoma Institute Australia have announced a new multi-year agreement to provide enhanced support services for patients nationally. The agreement was announced at a Melanoma Information Forum held in Sydney, jointly hosted by both organisations. The forum detailed updates on treatments, surgery and strategies for living well and included expert advice from MIA Co-Medical Directors Professor Georgina Long and Professor Richard Scolyer.
The new MPA/MIA agreement will focus on:
- Introduction of a Tele Health Nurse Pilot Program to provide better access of services for melanoma patients
- Increased capacity and expertise of MPA’s Peer to Peer volunteer facilitators and volunteer support staff
- Enhanced face to face support groups within NSW and integration of these into MPA’s national support network
- Joint involvement in events including patient information sessions and MIA’s national Melanoma March campaign.
‘Both organisations look forward to partnering more closely to deliver enhanced support services to melanoma patients nationally,’ said Matthew Browne, CEO of Melanoma Institute Australia.
‘We are very excited and proud to be working with the incredible team at Melanoma Institute Australia,’ said Victoria Beedle, CEO of Melanoma Patients Australia. ‘MIA’s goal is zero deaths from melanoma achieved through research into new and exciting treatments for patients. With survival rates continuing to improve, the need for this collaboration to strengthen the Support Services available to our patients and families, is, thankfully, even greater. With this partnership we will achieve national synergies and strength from our collective efforts to raise awareness of melanoma in the community.’
MIA leads world-class skin tumour pathology conference
Professor Richard Scolyer, Co-Medical Director of Melanoma Institute Australia, will welcome international attendees this weekend to a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
MAFS, it is time for a reality check on solariums.
It is time for a reality check on solariums.
They have no place in anyone’s beauty routine.
Community Fundraising January Wrap-Up
Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
Kyly Clarke urges Aussies to step up to save lives from melanoma
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Improving support for our patients across Australia.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Boost to melanoma support in WA
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
New Test to Predict Primary Melanoma Progression
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
Community Fundraising December Wrap-Up
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Two melanoma treatments approved for PBS listing
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
Immunotherapy: the decade's biggest health advance
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Boost to Melanoma Services in the Riverina
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Winner of the SunSafe Student Ambassador Program announced
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
Community Fundraising November Wrap-Up
It’s time again to say thank you to our amazing community fundraisers!
MIA & MPA Patient Information Evening videos now available
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA shines in poster session
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.
MIA Co-Medical Director opens SMR Congress in USA
Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
Highly Cited Researchers List names MIA Co-Medical Directors
MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.
MPA and MIA collaboration
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
Community Fundraising October Wrap-Up
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
Promising data for advanced melanoma patients
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.